| 注册
首页|期刊导航|中国临床药理学与治疗学|三维细胞模型在抗肿瘤药物早期药代动力学筛选中的应用进展

三维细胞模型在抗肿瘤药物早期药代动力学筛选中的应用进展

鲁萌 周芳 刘嘉莉 贾元威 倪苹 王广基 张经纬

中国临床药理学与治疗学2017,Vol.22Issue(3):342-349,8.
中国临床药理学与治疗学2017,Vol.22Issue(3):342-349,8.

三维细胞模型在抗肿瘤药物早期药代动力学筛选中的应用进展

Application advance on screening of anti-cancer drugs in the early stage of pharmacokinetics based on 3D cell culture model

鲁萌 1周芳 2刘嘉莉 2贾元威 2倪苹 3王广基 2张经纬2

作者信息

  • 1. 南京大学医学院附属鼓楼医院国家药物临床试验机构,南京210008,江苏
  • 2. 中国药科大学药物代谢动力学重点实验室,南京210009,江苏
  • 3. 皖南医学院第一附属医院弋矶山医院临床药学部,芜湖241001,安徽
  • 折叠

摘要

Abstract

Despite significant improvements in ways to treat cancer,numerous patients still die from it.One of the important reasons for this problem is that high failure of clinical transformation ratio due largely to poor PK/PD behavior.As time moves on,many new data increasingly reveal that traditional pharmacokinetics study in vivo cannot totally explain the efficacy of drug targeting on the intra-cell.Previously 2D cell culture has been the most popular in vivo models in drug screening and R&D.However,2D cell culture techniques do not faithfully replicate all of the mechanical and biochemical signals present in vivo.It is necessary to improve the early drug developmental stage to evaluate new drugs or drug combinations.3D cell culture systems can reproduce the characteristics of solid tumors in vivo vividly.Growing cells such as 3D models used in cellular pharmacokinetics break a new through on cell based assay and evaluation of anti-cancer drugs.This review aims first to shortly report on 3D culture systems currently and second to introduce the applications and advantages of cellular pharmacokinetics evaluation of anti-cancer drugs based on 3 D cell model.

关键词

三维细胞/药代动力学/肿瘤微环境/早期药物筛选

Key words

3D cell culture/pharmacokinetics/tumor microenvironment/early drug screening

分类

医药卫生

引用本文复制引用

鲁萌,周芳,刘嘉莉,贾元威,倪苹,王广基,张经纬..三维细胞模型在抗肿瘤药物早期药代动力学筛选中的应用进展[J].中国临床药理学与治疗学,2017,22(3):342-349,8.

基金项目

国家自然科学基金面上项目(81573494) (81573494)

国家自然科学基金青年项目(81503236) (81503236)

江苏省自然科学基金青年项目(BK20160108) (BK20160108)

安徽省科技厅自然科学基金项目(1608085QH212) (1608085QH212)

南京大学中央高校基本科研业务费项目(021414380173) (021414380173)

安徽省高校优秀青年人才支持计划重点项目(gxyqZD2016178) (gxyqZD2016178)

中国临床药理学与治疗学

OACSCDCSTPCD

1009-2501

访问量4
|
下载量0
段落导航相关论文